Asia pacific wound care biologics market
Asia Pacific Wound Care Biologics Market, By Product Type (Biologic Skin Substitutes, Enzyme Based Formulations, and Growth Factors), By Application (Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, and Pressure Ulcers) and Acute Wounds(Surgical Wounds, Burns)), By End User (Hospital (In-patient Settings and Out-patient Settings), Clinics, Ambulatory Surgical Centers, and Home Care Settings), and By Country (China, India, Japan, Australia, South Korea, ASEAN, and Rest of APAC) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
- Jun 2022
- CMI5043
- 156 Pages
- Excel & Pdf
- Biotechnology
Wound care biologics refer to drugs extracted or semi-synthesized from natural sources which are used for controlling and healing infections. Wound care biologics are one of the widely preferred treatments in case of burns, as they enable fast recovery with minimum or no complications. Wound care biologics are mainly used for the management of diabetic, venous, arterial, and pressure ulcers.
The Asia Pacific wound care biologics market is estimated to be valued at US$ 296.1 Mn in 2022 and expected to exhibit a CAGR of 7.6% during the forecast period (2022-2030).
Figure 1. Asia Pacific Wound Care Biologics Market Share (%) in Terms of Value, By Product Type, 2022
The increasing prevalence of diabetes is expected to drive the market growth during the forecast period.
The increasing prevalence of diabetes in Asia is expected to drive the Asia Pacific wound care biologics market growth over the forecast period. For instance, according to the data published in Journal of Diabetology in 2018, the number of people with diabetes in Southeast Asia in 2017 was 80 million, and this is expected to increase to 151 million by 2045.
Asia Pacific Wound Care Biologics Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2021 | Market Size in 2022: | US$ 296.1 Mn |
Historical Data for: | 2017 to 2020 | Forecast Period: | 2022 to 2030 |
Forecast Period 2022 to 2030 CAGR: | 7.6% | 2030 Value Projection: | US$ 533.8 Mn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
Smith & Nephew Plc, Organogenesis, Inc., Integra LifeSciences Holdings Corporation, Skye Biologics, Alphatec Holdings, Inc., Solsys Medical LLC, Amnio Technology LLC, Osiris Therapeutics, Inc., Anika Therapeutics, Inc., Zimmer Biomet, Wright Medical Group N.V., and Kerecis. |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Figure 2. Asia Pacific Wound Care Biologics Market Share (%), By Application, 2022
The rising incidence of chronic wounds and ulcers is expected to drive the market growth during the forecast period.
The rising incidence of chronic wounds and ulcers is expected to propel the Asia Pacific wound care biologics market growth over forecast period. For instance, according to data published by the World Health Organization (WHO) in March 2018, over 1,000,000 people were moderately or severely burnt every year in India
Asia Pacific Wound Care Biologics Market – Impact of Coronavirus (COVID-19) Pandemic
Supply chain and manufacturing activities in India and China have been disrupted due to lockdowns implemented by governments for the past two years. The coronavirus or COVID-19 outbreak that started from Wuhan, China has spread across continents, affecting various industries globally. The supply of key materials has been severely disrupted due to forced quarantine and lack of labor and raw materials. As the link between regional warehouses is not smooth, the transportation of raw materials between regions cannot be carried out successfully. This shortage of raw materials and components has affected the supply chain of the Asia Pacific wound care biologics market. Due to a severe shortage of medical resources at the front line, only patients diagnosed with serious conditions can be hospitalized. Unfortunately, the pathogenic mechanism of the virus has not been identified completely, and therefore, there is no specific drug and treatment except for symptomatic and supportive treatments. Respiratory support devices such as life-support machines, atomizer, oxygen generators, and monitors are primary clinical treatment medical devices for the COVID-19. Thus, from diagnosis to cure, the need for instruments for measuring temperature, nucleic acid diagnostic kits, antiviral medical products, and life-support machines have increased consistently. Furthermore, the COVID-19 pandemic has impacted the global economy, and in turn, the Asia Pacific wound care biologics market. Quarantines, traveling constraints, and social distancing measures are likely to lead to a steep decline in business and consumer spending.
Asia Pacific Wound Care Biologics Market: Restraint
The major factors that may hinder the Asia Pacific wound care biologics market growth include the increasing adoption of alternative wound care products. Wound care biologic products are relatively expensive, significantly contributing towards the cost of total wound management procedure, thereby deterring the patients from seeking advanced wound care. This is a major factor responsible for the increasing inclination of patients towards traditional wound care management techniques such as traditional and antimicrobial dressing.
Key Players
Major players operating in the Asia Pacific wound care biologics market include Smith & Nephew Plc, Organogenesis, Inc., Integra LifeSciences Holdings Corporation, Skye Biologics, Alphatec Holdings, Inc., Solsys Medical LLC, Amnio Technology LLC, Osiris Therapeutics, Inc., Anika Therapeutics, Inc., Zimmer Biomet, Wright Medical Group N.V., and Kerecis.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Regulatory Scenario
- PEST Analysis
- Epidemiology
- Product Launch/Approvals
- Acquisition, Collaboration & Agreements
- Key Developments
- Alternative Wound Care Management Products
- Market Dynamics
- Asia Pacific Wound Care Biologics Market– Impact of Coronavirus (COVID-19) Pandemic
- Impact of Covid-19 on Supply and Demand
- Government Initiative
- Asia Pacific Wound Care Biologics Market, By Product Type, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018– 2030
- Segment Trends
- Biologic Skin Substitutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
- Enzyme Based Formulations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
- Growth Factors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
- Introduction
- Asia Pacific Wound Care Biologics Market, By Application, 2017 – 2030, (US$ Mn)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Chronic Wounds
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Acute Wounds
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
- Surgical Wounds
- Burns
- Overview
- Asia Pacific Wound Care Biologics Market, By End User, 2017 – 2030, (US$ Mn)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
- In-patient Settings
- Out-patient Settings
- Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
- Home Care Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Mn)
- Overview
- Asia Pacific Wound Care Biologics Market, By Country, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2030
- Regional Trends
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Mn)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Mn)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Mn)
- Australia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Mn)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Mn)
- ASEAN
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Mn)
- Rest of APAC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2030, (US$ Mn)
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Smith & Nephew Plc*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Organogenesis, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Integra LifeSciences Holdings Corporation
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Skye Biologics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Alphatec Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Solsys Medical LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Amnio Technology LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Osiris Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Anika Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Zimmer Biomet
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Wright Medical Group N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Kerecis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategy
- Smith & Nephew Plc*
- Analyst Views
- Section
- Research Methodology
- About Us
*Browse 27 market data tables and 31 figures on "Asia Pacific Wound Care Biologics Market” – Asia Pacific Forecast to 2030
Detailed Segmentation:
- Asia Pacific Wound Care Biologics Market, By Product Type:
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
- Asia Pacific Wound Care Biologics Market, By Application:
- Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Acute Wounds
- Surgical Wounds
- Burns
- Chronic Wounds
- Asia Pacific Wound Care Biologics Market, By End User:
- Hospitals
- In-patient Settings
- Out-patient Settings
- Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Hospitals
- Asia Pacific Wound Care Biologics Market, By Country:
- China
- By Product Type
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
- By Application
- Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Acute Wounds
- Surgical Wounds
- Burns
- Chronic Wounds
- By End User
- Hospitals
- In-patient Setting
- Out-patient Settings
- Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Hospitals
- By Product Type
- India
- By Product Type
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
- By Application
- Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Acute Wounds
- Surgical Wounds
- Burns
- Chronic Wounds
- By End User
- Hospitals
- In-patient Setting
- Out-patient Settings
- Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Hospitals
- By Product Type
- Japan
- By Product Type
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
- By Application
- Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Acute Wounds
- Surgical Wounds
- Burns
- Chronic Wounds
- By End User
- Hospitals
- In-patient Setting
- Out-patient Settings
- Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Hospitals
- By Product Type
- Australia
- By Product Type
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
- By Application
- Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Acute Wounds
- Surgical Wounds
- Burns
- Chronic Wounds
- By End User
- Hospitals
- In-patient Setting
- Out-patient Settings
- Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Hospitals
- By Product Type
- South Korea
- By Product Type
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
- By Application
- Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Acute Wounds
- Surgical Wounds
- Burns
- Chronic Wounds
- By End User
- Hospitals
- In-patient Setting
- Out-patient Settings
- Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Hospitals
- By Product Type
- ASEAN
- By Product Type
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
- By Application
- Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Acute Wounds
- Surgical Wounds
- Burns
- Chronic Wounds
- By End User
- Hospitals
- In-patient Setting
- Out-patient Settings
- Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Hospitals
- By Product Type
- Rest of APAC
- By Product Type
- Biologic Skin Substitutes
- Enzyme Based Formulations
- Growth Factors
- By Application
- Chronic Wounds
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Acute Wounds
- Surgical Wounds
- Burns
- Chronic Wounds
- By End User
- Hospitals
- In-patient Setting
- Out-patient Settings
- Clinics
- Ambulatory Surgical Centers
- Home Care Setting
- Hospitals
- By Product Type
- China